Accelerating clinical impact requires innovative outsourcing. Through parallel integration of our development platform with preclinical drug discovery, our comprehensive discovery-to-IND program offers a completely new path for drug developers that is faster, easier, and more predictable.
Our discovery-to-IND program cuts clinical scale-up timelines in half, saving 6-9 months on your way to the clinic. Built for speed, our fixed fees, guaranteed timelines, and minimum yield of GMP drug substance ensure that your critical Phase 1 milestones are predictably achieved.
We are a growing team of drug development professionals who share a passion for speed to clinical impact through collaboration.